BioNxt Solutions Inc. (CNSX: BNXT)
Health Care · Pharmaceuticals · CA
CA$0.34
+1.49% today · -67.6% 1Y
BioNxt Solutions Inc. (CNSX: BNXT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $33.60M and employs 25 people.
Over the last twelve months the share price has lost 67.6%, trading between 0.28 and 1.06.
Tweenvest scores BioNxt Solutions Inc. across four factors: quality 5/100. Its strongest factor is quality.
BNXT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.60M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- 1.47
- 52-week high
- CA$1.06
- 52-week low
- CA$0.28
- Avg volume (3M)
- —
- Shares outstanding
- 136.06M
- Employees
- 25
- Next earnings
- —
About BioNxt Solutions Inc.
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
- ISIN
- CA0909741062
- Founded
- 2017
- Listed since
- Aug 6, 2019
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.